|
AbbVie
|
| 100 % ▼ |
United States
|
USU0029QAN61 ( in USD )
|
|
2.3% per year ( payment 2 times a year) |
| 11/21/2022 - Bond has expired
|
|
| 2 000 USD |
| 3 000 000 000 USD
|
|
U0029QAN6
|
|
BBB+ ( Lower medium grade - Investment-grade )
|
|
N/A
|
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology.
The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code USU0029QAN61, pays a coupon of 2.3% per year. The coupons are paid 2 times per year and the Bond maturity is 11/21/2022 The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code USU0029QAN61,
was rated BBB+ ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency.
|
| Date | Clean price |
|---|
| 08/07/2024 | 100.00% | | 11/15/2022 | 103.87% | | 10/23/2022 | 103.87% | | 10/02/2022 | 103.87% | | 09/11/2022 | 103.87% | | 08/21/2022 | 103.87% | | 07/31/2022 | 103.87% | | 07/10/2022 | 103.87% | | 06/19/2022 | 103.87% | | 05/29/2022 | 103.87% | | 05/08/2022 | 103.87% | | 04/17/2022 | 103.87% | | 04/02/2022 | 103.87% | | 03/18/2022 | 103.87% | | 03/03/2022 | 103.87% | | 02/14/2022 | 103.87% | | 01/28/2022 | 103.87% | | 01/08/2022 | 103.87% | | 12/18/2021 | 103.87% | | 11/27/2021 | 103.87% | | 11/06/2021 | 103.87% | | 10/16/2021 | 103.87% | | 09/25/2021 | 103.87% | | 09/04/2021 | 103.87% | | 08/14/2021 | 103.87% | | 07/24/2021 | 103.87% | | 07/03/2021 | 103.87% | | 06/12/2021 | 103.87% | | 05/22/2021 | 103.87% | | 05/05/2021 | 103.60% | | 04/14/2021 | 103.60% | | 03/26/2021 | 103.60% | | 03/09/2021 | 103.60% | | 02/20/2021 | 103.60% | | 02/04/2021 | 103.60% | | 01/22/2021 | 103.60% | | 01/10/2021 | 103.60% | | 12/30/2020 | 103.60% | | 12/14/2020 | 103.60% | | 12/01/2020 | 103.60% | | 11/17/2020 | 103.68% | | 11/12/2020 | 103.71% | | 10/31/2020 | 103.66% | | 10/23/2020 | 103.67% | | 10/15/2020 | 103.64% | | 10/07/2020 | 102.90% | | 09/30/2020 | 102.94% | | 09/23/2020 | 103.04% | | 09/16/2020 | 103.58% | | 09/09/2020 | 103.10% | | 09/02/2020 | 103.90% | | 08/26/2020 | 103.10% | | 08/19/2020 | 103.91% | | 08/11/2020 | 103.81% | | 08/04/2020 | 103.49% | | 07/28/2020 | 103.52% | | 07/21/2020 | 103.63% | | 07/13/2020 | 103.50% | | 07/05/2020 | 103.36% | | 06/28/2020 | 103.37% | | 06/21/2020 | 103.34% | | 06/13/2020 | 103.03% | | 06/09/2020 | 103.34% | | 06/05/2020 | 103.20% | | 06/01/2020 | 102.81% | | 05/28/2020 | 102.92% | | 05/24/2020 | 102.77% | | 05/20/2020 | 102.74% | | 05/16/2020 | 102.40% | | 05/12/2020 | 102.15% | | 05/09/2020 | 102.78% | | 05/05/2020 | 102.77% | | 05/01/2020 | 102.54% | | 04/27/2020 | 100.12% | | 04/23/2020 | 100.12% | | 04/20/2020 | 100.12% | | 04/16/2020 | 100.12% | | 04/12/2020 | 100.12% | | 04/09/2020 | 100.12% | | 04/05/2020 | 100.12% | | 04/02/2020 | 100.12% | | 03/29/2020 | 100.12% | | 03/26/2020 | 100.12% | | 03/22/2020 | 100.12% | | 03/19/2020 | 100.12% | | 03/16/2020 | 100.12% | | 03/13/2020 | 100.12% | | 03/09/2020 | 100.12% | | 03/06/2020 | 100.12% | | 03/03/2020 | 100.12% | | 02/29/2020 | 100.12% | | 02/26/2020 | 100.12% | | 02/23/2020 | 100.12% | | 02/20/2020 | 100.12% | | 02/17/2020 | 100.12% | | 02/14/2020 | 100.12% | | 02/11/2020 | 100.12% | | 02/08/2020 | 100.12% | | 02/04/2020 | 100.12% | | 02/01/2020 | 100.12% | | 01/29/2020 | 100.12% | | 01/26/2020 | 100.12% | | 01/23/2020 | 100.12% | | 01/20/2020 | 100.12% | | 01/17/2020 | 100.12% | | 01/14/2020 | 100.12% | | 01/11/2020 | 100.12% | | 01/08/2020 | 100.12% | | 01/05/2020 | 100.12% | | 01/02/2020 | 100.12% | | 12/30/2019 | 100.12% | | 12/27/2019 | 100.12% | | 12/24/2019 | 100.12% | | 12/21/2019 | 100.12% | | 12/18/2019 | 100.24% | | 12/15/2019 | 100.24% | | 12/10/2019 | 100.17% | | 12/03/2019 | 100.07% | | 11/27/2019 | 100.04% | | 11/20/2019 | 100.10% | | 11/16/2019 | 100.16% |
|